have evolved
Harnessing more of the immune system for better cancer outcomes
Latest News

We're looking for a highly skilled Senior Scientist to join our brilliant Functional Genomics & Screening Team. If this could be you, please respond to KSC 5-11 by Sunday 4 October 11:55pm AEDT.

#biotech #sci_jobs

Momentum is building in the allogenic CAR cell therapy space with CAR NK cells receiving a lot of attention @GileadSciences @KitePharma CSO comments on NK cell therapies in cancer via their partnership with @oNKo_innate

Load More...
Discover oNKo-innate
With our deep understanding of Natural Killer (NK) cells, we aim to be the first to master NK cell biology and therapeutically harness the cancer-fighting abilities of these remarkable white blood cells.
Learn more
Using powerful genomic approaches, we screen primary immune cells and cancer cells to understand their interaction within a tumor.
Learn more
o o
We are driven by the challenge of engaging the immune system to fight cancer, and focused on delivering the first truly effective NK cell immunotherapies.
Find out who we are